Teva Pharmaceutical Industries Ltd (TEVA) — Cash Flow Quality Index
Teva Pharmaceutical Industries Ltd (TEVA) has a Cash Flow Quality Index of 0.85x as of March 2026. Operating cash flow of ILA313.17 Million is below net income of ILA370.02 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Teva Pharmaceutical Industries Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Teva Pharmaceutical Industries Ltd Cash Flow Quality Index (1991–2025)
Historical Cash Flow Quality Index for Teva Pharmaceutical Industries Ltd across 29 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Teva Pharmaceutical Industries Ltd (TEVA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year earnings quality comparison for Teva Pharmaceutical Industries Ltd. For live market cap and the full company financial profile, see Teva Pharmaceutical Industries Ltd market cap and net worth.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.03x | ILA3.10 Billion | ILA1.53 Billion | ▲ +15.9% |
| 2021 | 1.75x | ILA798.00 Million | ILA456.00 Million | ▼ -75.3% |
| 2019 | 7.08x | ILA538.00 Million | ILA76.00 Million | ▼ -57.9% |
| 2016 | 16.80x | ILA5.22 Billion | ILA311.00 Million | ▲ +384.1% |
| 2015 | 3.47x | ILA5.54 Billion | ILA1.60 Billion | ▲ +105.9% |
| 2014 | 1.69x | ILA5.13 Billion | ILA3.04 Billion | ▼ -34.8% |
| 2013 | 2.58x | ILA3.24 Billion | ILA1.25 Billion | ▲ +7.9% |
| 2012 | 2.39x | ILA4.57 Billion | ILA1.91 Billion | ▲ +60.3% |
| 2011 | 1.49x | ILA4.13 Billion | ILA2.77 Billion | ▲ +20.6% |
| 2010 | 1.24x | ILA4.14 Billion | ILA3.34 Billion | ▼ -26.4% |
| 2009 | 1.68x | ILA3.37 Billion | ILA2.00 Billion | ▼ -66.9% |
| 2008 | 5.09x | ILA3.23 Billion | ILA635.00 Million | ▲ +447.8% |
| 2007 | 0.93x | ILA1.81 Billion | ILA1.95 Billion | ▼ -75.4% |
| 2006 | 3.77x | ILA2.06 Billion | ILA546.00 Million | ▲ +195.0% |
| 2005 | 1.28x | ILA1.37 Billion | ILA1.07 Billion | ▼ -66.1% |
| 2004 | 3.76x | ILA1.25 Billion | ILA331.80 Million | ▲ +315.1% |
| 2003 | 0.91x | ILA626.60 Million | ILA691.00 Million | ▲ +5.2% |
| 2002 | 0.86x | ILA353.70 Million | ILA410.30 Million | ▼ -12.2% |
| 2001 | 0.98x | ILA273.15 Million | ILA278.21 Million | ▼ -12.0% |
| 2000 | 1.12x | ILA165.63 Million | ILA148.42 Million | ▼ -14.4% |
| 1999 | 1.30x | ILA153.61 Million | ILA117.83 Million | ▲ +27.8% |
| 1998 | 1.02x | ILA70.20 Million | ILA68.80 Million | ▼ -46.5% |
| 1997 | 1.91x | ILA193.60 Million | ILA101.50 Million | ▲ +2158.9% |
| 1996 | -0.09x | ILA-6.80 Million | ILA73.40 Million | ▼ -107.0% |
| 1995 | 1.32x | ILA105.40 Million | ILA79.80 Million | ▲ +147.6% |
| 1994 | 0.53x | ILA38.20 Million | ILA71.60 Million | ▼ -18.6% |
| 1993 | 0.66x | ILA37.70 Million | ILA57.50 Million | ▼ -24.2% |
| 1992 | 0.87x | ILA28.20 Million | ILA32.60 Million | ▲ +125.3% |
| 1991 | 0.38x | ILA9.10 Million | ILA23.70 Million | — |